US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
EP0602586B1
(de)
*
|
1992-12-16 |
1997-06-04 |
Takeda Chemical Industries, Ltd. |
Stabile pharmazeutische Zubereitung mit Fumagillolderivaten
|
US5994341A
(en)
*
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
DK1155689T3
(da)
*
|
1993-07-19 |
2006-11-20 |
Angiotech Pharm Inc |
Antiangiogene stents og fremgangsmåder til fremstilling heraf
|
US20030203976A1
(en)
|
1993-07-19 |
2003-10-30 |
William L. Hunter |
Anti-angiogenic compositions and methods of use
|
AU771815B2
(en)
*
|
1993-07-19 |
2004-04-01 |
Angiotech Pharmaceuticals, Inc. |
Anti-angiogenic compositions and methods of use
|
AU728873B2
(en)
*
|
1993-07-19 |
2001-01-18 |
Angiotech Pharmaceuticals, Inc. |
Anti-angiogenic compositions and methods of use
|
DE69417169T2
(de)
*
|
1993-09-24 |
1999-07-22 |
Takeda Chemical Industries Ltd |
Antineoplastische pharmazeutische Zusammensetzung enthaltend ein Fumagillolderivat und einen Platinkomplex
|
US5753230A
(en)
*
|
1994-03-18 |
1998-05-19 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of angiogenesis
|
JP2535785B2
(ja)
*
|
1994-06-03 |
1996-09-18 |
工業技術院長 |
血管塞栓剤
|
US6558798B2
(en)
|
1995-02-22 |
2003-05-06 |
Scimed Life Systems, Inc. |
Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity
|
US5667767A
(en)
*
|
1995-07-27 |
1997-09-16 |
Micro Therapeutics, Inc. |
Compositions for use in embolizing blood vessels
|
US5580568A
(en)
*
|
1995-07-27 |
1996-12-03 |
Micro Therapeutics, Inc. |
Cellulose diacetate compositions for use in embolizing blood vessels
|
CN1079642C
(zh)
*
|
1995-07-27 |
2002-02-27 |
微治疗公司 |
新型栓塞组合物
|
KR970069028A
(ko)
*
|
1996-04-01 |
1997-11-07 |
김은영 |
화학색전용 에멀젼의 제조방법
|
RU2195312C2
(ru)
|
1996-05-31 |
2002-12-27 |
Дзе Скриппс Рисерч Инститьют |
СПОСОБЫ И КОМПОЗИЦИИ, ИСПОЛЬЗУЕМЫЕ ДЛЯ ИНГИБИРОВАНИЯ αvβ5-ОПОСРЕДОВАННОГО АНГИОГЕНЕЗА
|
DE69718180T2
(de)
*
|
1996-05-31 |
2003-08-21 |
Micro Therapeutics Inc |
Zusammensetzungen zur verwendung bei der embolisierung von blutgefässen
|
US5695480A
(en)
*
|
1996-07-29 |
1997-12-09 |
Micro Therapeutics, Inc. |
Embolizing compositions
|
US5925683A
(en)
*
|
1996-10-17 |
1999-07-20 |
Target Therapeutics, Inc. |
Liquid embolic agents
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
US5837283A
(en)
|
1997-03-12 |
1998-11-17 |
The Regents Of The University Of California |
Cationic lipid compositions targeting angiogenic endothelial cells
|
US7112338B2
(en)
*
|
1997-03-12 |
2006-09-26 |
The Regents Of The University Of California |
Cationic liposome delivery of taxanes to angiogenic blood vessels
|
WO1998047532A1
(en)
*
|
1997-04-24 |
1998-10-29 |
Nycomed Imaging As |
Embolus therapy using insoluble microparticles or vesicles containing contrast agents
|
GB9727518D0
(en)
*
|
1997-12-31 |
1998-02-25 |
Nycomed Imaging As |
Use
|
EP0927558A1
(de)
*
|
1997-12-31 |
1999-07-07 |
Nycomed Imaging As |
Tenside enthaltendes Mittel zum Embolisieren
|
US6660301B1
(en)
|
1998-03-06 |
2003-12-09 |
Biosphere Medical, Inc. |
Injectable microspheres for dermal augmentation and tissue bulking
|
US7208010B2
(en)
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
US20040254635A1
(en)
|
1998-03-30 |
2004-12-16 |
Shanley John F. |
Expandable medical device for delivery of beneficial agent
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
FR2784580B1
(fr)
|
1998-10-16 |
2004-06-25 |
Biosepra Inc |
Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
|
US6293967B1
(en)
|
1998-10-29 |
2001-09-25 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
US20050281821A1
(en)
*
|
1999-01-06 |
2005-12-22 |
Flavia Pernasetti |
Method and composition for angiogenesis inhibition
|
US6120847A
(en)
*
|
1999-01-08 |
2000-09-19 |
Scimed Life Systems, Inc. |
Surface treatment method for stent coating
|
US6419692B1
(en)
|
1999-02-03 |
2002-07-16 |
Scimed Life Systems, Inc. |
Surface protection method for stents and balloon catheters for drug delivery
|
US6156373A
(en)
*
|
1999-05-03 |
2000-12-05 |
Scimed Life Systems, Inc. |
Medical device coating methods and devices
|
EP1987847A1
(de)
|
1999-05-21 |
2008-11-05 |
Micro Therapeutics, Inc. |
Neuartige Embolisierungszusammensetzungen mit hoher Viskosität
|
US6258121B1
(en)
|
1999-07-02 |
2001-07-10 |
Scimed Life Systems, Inc. |
Stent coating
|
AU6058000A
(en)
*
|
1999-07-12 |
2001-01-30 |
Scimed Life Systems, Inc. |
Liquid based vaso-occlusive compositions
|
IL148372A0
(en)
*
|
1999-09-09 |
2002-09-12 |
Univ California |
Cationic liposome delivery of taxanes to angiogenic blood vessels
|
PL356815A1
(en)
|
1999-12-22 |
2004-07-12 |
The Scripps Research Institute |
Angiogenesis and vascular permeability modulators and inhibitors
|
WO2001068720A1
(en)
|
2000-03-13 |
2001-09-20 |
Biocure, Inc. |
Embolic compositions
|
EP1263801B1
(de)
*
|
2000-03-13 |
2006-05-24 |
BioCure, Inc. |
Zusammensetzungen zur erhöhung des gewebevolumens und beschichtungszusammensetzungen
|
EP1274472A2
(de)
|
2000-03-20 |
2003-01-15 |
Biosphere Medical, Inc. |
Injizierbare und schwellfähige mikrokügelchen zur gewebeverstärkung
|
US6436424B1
(en)
|
2000-03-20 |
2002-08-20 |
Biosphere Medical, Inc. |
Injectable and swellable microspheres for dermal augmentation
|
US7338657B2
(en)
*
|
2001-03-15 |
2008-03-04 |
Biosphere Medical, Inc. |
Injectable microspheres for tissue construction
|
EP2286799B1
(de)
|
2000-03-24 |
2015-07-29 |
Biosphere Medical, Inc. |
Mikrokugeln zur aktiven Embolisation
|
US20030212022A1
(en)
*
|
2001-03-23 |
2003-11-13 |
Jean-Marie Vogel |
Compositions and methods for gene therapy
|
US6355275B1
(en)
|
2000-06-23 |
2002-03-12 |
Carbon Medical Technologies, Inc. |
Embolization using carbon coated microparticles
|
US6394965B1
(en)
|
2000-08-15 |
2002-05-28 |
Carbon Medical Technologies, Inc. |
Tissue marking using biocompatible microparticles
|
JP4817088B2
(ja)
*
|
2000-10-10 |
2011-11-16 |
株式会社林原生物化学研究所 |
塞栓材料
|
US6764507B2
(en)
|
2000-10-16 |
2004-07-20 |
Conor Medsystems, Inc. |
Expandable medical device with improved spatial distribution
|
CZ20031262A3
(en)
*
|
2000-10-16 |
2004-03-17 |
Neopharm, Inc. |
Liposomal formulation of mitoxantrone
|
AU2001294634B2
(en)
|
2000-10-16 |
2006-07-06 |
Innovational Holdings, Llc |
Expandable medical device for delivery of beneficial agent
|
US6648911B1
(en)
|
2000-11-20 |
2003-11-18 |
Avantec Vascular Corporation |
Method and device for the treatment of vulnerable tissue site
|
US20040073294A1
(en)
|
2002-09-20 |
2004-04-15 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
US6815426B2
(en)
*
|
2001-02-16 |
2004-11-09 |
E. I. Du Pont De Nemours And Company |
Angiogenesis-inhibitory tripeptides, compositions and their methods of use
|
US20040185101A1
(en)
*
|
2001-03-27 |
2004-09-23 |
Macromed, Incorporated. |
Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
|
US7052468B2
(en)
*
|
2001-05-24 |
2006-05-30 |
University Of Florida Research Foundation, Inc. |
Method and apparatus for detecting environmental smoke exposure
|
US7365167B2
(en)
*
|
2001-11-26 |
2008-04-29 |
Cell Matrix, Inc. |
Humanized collagen antibodies and related methods
|
US7390885B2
(en)
*
|
2001-11-26 |
2008-06-24 |
Cell Matrix, Inc. |
Humanized collagen antibodies and related methods
|
US7462366B2
(en)
|
2002-03-29 |
2008-12-09 |
Boston Scientific Scimed, Inc. |
Drug delivery particle
|
US7131997B2
(en)
*
|
2002-03-29 |
2006-11-07 |
Scimed Life Systems, Inc. |
Tissue treatment
|
US7094369B2
(en)
*
|
2002-03-29 |
2006-08-22 |
Scimed Life Systems, Inc. |
Processes for manufacturing polymeric microspheres
|
US7053134B2
(en)
*
|
2002-04-04 |
2006-05-30 |
Scimed Life Systems, Inc. |
Forming a chemically cross-linked particle of a desired shape and diameter
|
US7341716B2
(en)
*
|
2002-04-12 |
2008-03-11 |
Boston Scientific Scimed, Inc. |
Occlusive composition
|
US7670623B2
(en)
|
2002-05-31 |
2010-03-02 |
Materials Modification, Inc. |
Hemostatic composition
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
EP1511522B1
(de)
|
2002-06-12 |
2011-08-10 |
Boston Scientific Limited |
Quellstoffe
|
US7097850B2
(en)
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
JP4393098B2
(ja)
*
|
2002-06-21 |
2010-01-06 |
独立行政法人科学技術振興機構 |
アンサマイシン系抗生物質の新規用途及び新規血管新生抑制物質のスクリーニング方法
|
DE20320989U1
(de)
*
|
2002-07-12 |
2005-09-15 |
Mycrona Ges Fuer Innovative Me |
Vorrichtung zur Bestimmung der Ist-Position einer Struktur eines Untersuchungsobjektes in einem Koordinatensystem
|
US7842377B2
(en)
*
|
2003-08-08 |
2010-11-30 |
Boston Scientific Scimed, Inc. |
Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
|
US7449236B2
(en)
*
|
2002-08-09 |
2008-11-11 |
Boston Scientific Scimed, Inc. |
Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
|
US8012454B2
(en)
|
2002-08-30 |
2011-09-06 |
Boston Scientific Scimed, Inc. |
Embolization
|
US8071569B2
(en)
*
|
2002-09-20 |
2011-12-06 |
Mousa Shaker A |
Oxidized heparin fractions and their use in inhibiting angiogenesis
|
WO2004035022A2
(en)
*
|
2002-10-15 |
2004-04-29 |
Microtherapeutics, Inc. |
Prepolymeric materials for site specific delivery to the body
|
US7883490B2
(en)
|
2002-10-23 |
2011-02-08 |
Boston Scientific Scimed, Inc. |
Mixing and delivery of therapeutic compositions
|
US7588825B2
(en)
*
|
2002-10-23 |
2009-09-15 |
Boston Scientific Scimed, Inc. |
Embolic compositions
|
US7560160B2
(en)
*
|
2002-11-25 |
2009-07-14 |
Materials Modification, Inc. |
Multifunctional particulate material, fluid, and composition
|
US20040161466A1
(en)
|
2003-02-14 |
2004-08-19 |
Biocompatibles Uk Limited |
Chemoembolisation
|
US7601694B2
(en)
*
|
2003-02-20 |
2009-10-13 |
New York University |
CLK-peptide and SLK-peptide
|
US7662783B2
(en)
*
|
2003-02-20 |
2010-02-16 |
New York University |
CLK-peptide and SLK-peptide
|
US7007972B1
(en)
|
2003-03-10 |
2006-03-07 |
Materials Modification, Inc. |
Method and airbag inflation apparatus employing magnetic fluid
|
US7387998B2
(en)
*
|
2003-03-28 |
2008-06-17 |
New York University |
STQ peptides
|
US6982501B1
(en)
|
2003-05-19 |
2006-01-03 |
Materials Modification, Inc. |
Magnetic fluid power generator device and method for generating power
|
US7200956B1
(en)
|
2003-07-23 |
2007-04-10 |
Materials Modification, Inc. |
Magnetic fluid cushioning device for a footwear or shoe
|
US7976823B2
(en)
*
|
2003-08-29 |
2011-07-12 |
Boston Scientific Scimed, Inc. |
Ferromagnetic particles and methods
|
US7785653B2
(en)
|
2003-09-22 |
2010-08-31 |
Innovational Holdings Llc |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
US7448389B1
(en)
|
2003-10-10 |
2008-11-11 |
Materials Modification, Inc. |
Method and kit for inducing hypoxia in tumors through the use of a magnetic fluid
|
US20050090804A1
(en)
*
|
2003-10-22 |
2005-04-28 |
Trivascular, Inc. |
Endoluminal prosthesis endoleak management
|
US7901770B2
(en)
*
|
2003-11-04 |
2011-03-08 |
Boston Scientific Scimed, Inc. |
Embolic compositions
|
AU2005215017A1
(en)
*
|
2004-02-17 |
2005-09-01 |
Cancervax Corporation |
Method and composition for angiogenesis inhibition
|
US7736671B2
(en)
*
|
2004-03-02 |
2010-06-15 |
Boston Scientific Scimed, Inc. |
Embolization
|
CN101072797B
(zh)
|
2004-03-12 |
2012-05-09 |
瓦斯基因治疗公司 |
结合ephb4、抑制血管发生和肿瘤生长的抗体
|
US8173176B2
(en)
|
2004-03-30 |
2012-05-08 |
Boston Scientific Scimed, Inc. |
Embolization
|
US20050238870A1
(en)
*
|
2004-04-22 |
2005-10-27 |
Marcia Buiser |
Embolization
|
US7311861B2
(en)
|
2004-06-01 |
2007-12-25 |
Boston Scientific Scimed, Inc. |
Embolization
|
KR101172722B1
(ko)
|
2004-06-15 |
2012-08-16 |
폴리메딕스, 인코포레이티드 |
다가양이온성 화합물 및 이의 용도
|
US7973134B2
(en)
*
|
2004-07-07 |
2011-07-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
|
EP1799713B1
(de)
|
2004-09-23 |
2014-11-05 |
VasGene Therapeutics, Inc. |
Polypeptidverbindungen zur hemmung von angiogenese und tumorwachstum
|
US7935790B2
(en)
*
|
2004-10-04 |
2011-05-03 |
Cell Singaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
|
US8425550B2
(en)
|
2004-12-01 |
2013-04-23 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
US7807789B2
(en)
*
|
2004-12-21 |
2010-10-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
|
US7858183B2
(en)
|
2005-03-02 |
2010-12-28 |
Boston Scientific Scimed, Inc. |
Particles
|
US7727555B2
(en)
*
|
2005-03-02 |
2010-06-01 |
Boston Scientific Scimed, Inc. |
Particles
|
US20060216236A1
(en)
*
|
2005-03-11 |
2006-09-28 |
Brooks Peter C |
Methods of inhibiting alphavBeta3-mediated angiogenesis and tumor development
|
US20060240002A1
(en)
*
|
2005-03-11 |
2006-10-26 |
Brooks Peter C |
Methods of inhibiting angiogenesis-dependent conditions mediated by cryptic epitopes of extracellular matrix components
|
US20060216237A1
(en)
*
|
2005-03-11 |
2006-09-28 |
Brooks Peter C |
Inhibition of angiogenesis and tumor development by IGFBP-4
|
US20090099340A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
US7963287B2
(en)
|
2005-04-28 |
2011-06-21 |
Boston Scientific Scimed, Inc. |
Tissue-treatment methods
|
CN104815331A
(zh)
|
2005-05-09 |
2015-08-05 |
生物领域医疗公司 |
使用微球和非离子型造影剂的组合物和方法
|
US20070004973A1
(en)
*
|
2005-06-15 |
2007-01-04 |
Tan Sharon M L |
Tissue treatment methods
|
US9463426B2
(en)
|
2005-06-24 |
2016-10-11 |
Boston Scientific Scimed, Inc. |
Methods and systems for coating particles
|
EP1928497A2
(de)
*
|
2005-08-24 |
2008-06-11 |
Cell-Matrix, Inc. |
Kombinationstherapien zur hemmung von interaktionen zwischen integrin und extrazellulärer matrix
|
EP1934867A2
(de)
*
|
2005-08-31 |
2008-06-25 |
Cell Signaling Technology, Inc. |
Reagentien zum nachweis der proteinphosphorylierung in leukämie-signalwegen
|
US20100151495A9
(en)
*
|
2005-08-31 |
2010-06-17 |
Cell Signaling Technolgy, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
US20070083219A1
(en)
*
|
2005-10-12 |
2007-04-12 |
Buiser Marcia S |
Embolic coil introducer sheath locking mechanisms
|
US8007509B2
(en)
*
|
2005-10-12 |
2011-08-30 |
Boston Scientific Scimed, Inc. |
Coil assemblies, components and methods
|
US8152839B2
(en)
|
2005-12-19 |
2012-04-10 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
US8101197B2
(en)
|
2005-12-19 |
2012-01-24 |
Stryker Corporation |
Forming coils
|
US20070142859A1
(en)
*
|
2005-12-19 |
2007-06-21 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
US7947368B2
(en)
*
|
2005-12-21 |
2011-05-24 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
US20070142560A1
(en)
*
|
2005-12-21 |
2007-06-21 |
Young-Ho Song |
Block copolymer particles
|
US7501179B2
(en)
*
|
2005-12-21 |
2009-03-10 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
US8075884B2
(en)
|
2006-01-12 |
2011-12-13 |
Alexion Pharmaceuticals, Inc. |
Antibodies to OX-2/CD200 and uses thereof
|
EP1986707A2
(de)
*
|
2006-01-30 |
2008-11-05 |
Surgica Corporation |
Komprimierbare intravaskuläre embolisationsteilchen und relevante verfahren und abgabesysteme
|
US20080039890A1
(en)
*
|
2006-01-30 |
2008-02-14 |
Surgica Corporation |
Porous intravascular embolization particles and related methods
|
WO2007127335A2
(en)
*
|
2006-04-27 |
2007-11-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in atm and atr kinase signaling pathways
|
US20070299461A1
(en)
*
|
2006-06-21 |
2007-12-27 |
Boston Scientific Scimed, Inc. |
Embolic coils and related components, systems, and methods
|
US7939636B2
(en)
*
|
2006-08-11 |
2011-05-10 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in c-Src signaling pathways
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
US8414927B2
(en)
|
2006-11-03 |
2013-04-09 |
Boston Scientific Scimed, Inc. |
Cross-linked polymer particles
|
WO2008073938A2
(en)
*
|
2006-12-11 |
2008-06-19 |
Pluromed, Inc. |
Perfusive organ hemostasis
|
US20080145658A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Boston Scientific Scimed, Inc. |
Freeze Thaw Methods For Making Polymer Particles
|
WO2008094708A2
(en)
|
2007-02-01 |
2008-08-07 |
Acceleron Pharma Inc. |
Activin-actriia antagonists and uses for treating or preventing breast cancer
|
EP1972639A3
(de)
|
2007-03-07 |
2008-12-03 |
Cell Signaling Technology, Inc. |
Reagenzien zur Erkennung von Proteinphosphorylierung in Karzinom-Signalwegen
|
EP1975184A3
(de)
|
2007-03-26 |
2008-11-26 |
Cell Signaling Technology, Inc. |
Serin- oder Threonin-Phosphorylationsorte
|
US20080238709A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Faramarz Vaziri |
One-way communication apparatus with dynamic key generation
|
US9717584B2
(en)
*
|
2007-04-13 |
2017-08-01 |
W. L. Gore & Associates, Inc. |
Medical apparatus and method of making the same
|
US20080255678A1
(en)
*
|
2007-04-13 |
2008-10-16 |
Cully Edward H |
Medical apparatus and method of making the same
|
US9642693B2
(en)
*
|
2007-04-13 |
2017-05-09 |
W. L. Gore & Associates, Inc. |
Medical apparatus and method of making the same
|
EP1983003A3
(de)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosinphosphorylationsstellen und spezifische Antikörper
|
EP2145902A3
(de)
|
2007-04-19 |
2010-09-29 |
Peter Hornbeck |
Tyrosinphosphorylations-Stellen und spezifische Antikörper
|
US7977462B2
(en)
|
2007-04-19 |
2011-07-12 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
US20090053831A1
(en)
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
EP2207562B1
(de)
|
2007-09-18 |
2017-05-31 |
Acceleron Pharma, Inc. |
Activin-actriia antagonisten und verfahren zur verringerung oder inhibierung der fsh-sekretion
|
US8066755B2
(en)
|
2007-09-26 |
2011-11-29 |
Trivascular, Inc. |
System and method of pivoted stent deployment
|
US8226701B2
(en)
|
2007-09-26 |
2012-07-24 |
Trivascular, Inc. |
Stent and delivery system for deployment thereof
|
US8663309B2
(en)
|
2007-09-26 |
2014-03-04 |
Trivascular, Inc. |
Asymmetric stent apparatus and method
|
US10159557B2
(en)
|
2007-10-04 |
2018-12-25 |
Trivascular, Inc. |
Modular vascular graft for low profile percutaneous delivery
|
WO2009064697A2
(en)
*
|
2007-11-13 |
2009-05-22 |
Boston Scientific Scimed, Inc. |
Combination coil and liquid embolic for embolization
|
US8083789B2
(en)
|
2007-11-16 |
2011-12-27 |
Trivascular, Inc. |
Securement assembly and method for expandable endovascular device
|
US8328861B2
(en)
|
2007-11-16 |
2012-12-11 |
Trivascular, Inc. |
Delivery system and method for bifurcated graft
|
EP2062920A3
(de)
|
2007-11-21 |
2009-06-17 |
Peter Hornbeck |
Proteinphosphorylation durch basophilische Serin-/Threonin-Kinasen in Insulinsignalisierungspfaden
|
US20090220991A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
US8591921B2
(en)
*
|
2008-04-10 |
2013-11-26 |
Virginia Commonwealth University |
Induction of tumor hypoxia for cancer therapy
|
US8246876B2
(en)
*
|
2008-08-18 |
2012-08-21 |
Cook Medical Technologies Llc |
Embolization particles and method for making same
|
WO2010044842A1
(en)
*
|
2008-10-16 |
2010-04-22 |
University Of Tennessee Research Foundation |
Tamper resistant oral dosage forms containing an embolizing agent
|
WO2010062678A2
(en)
*
|
2008-10-30 |
2010-06-03 |
David Liu |
Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same
|
CN101536986B
(zh)
*
|
2009-04-16 |
2011-05-04 |
北京圣医耀科技发展有限责任公司 |
含索拉非尼的海藻酸钠靶向缓释微球血管栓塞剂及其制备和应用
|
DE102009051575A1
(de)
*
|
2009-10-26 |
2011-04-28 |
NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen |
Verwendung von biokompatiblen Zusammensetzungen und hieraus polymerisierten Materialien zur Inhibierung der Angiogenese
|
JP6094219B2
(ja)
|
2011-03-30 |
2017-03-15 |
東レ株式会社 |
生分解性粒子、血管塞栓材料及び生分解性粒子の製造方法
|
CN104185480B
(zh)
|
2012-03-28 |
2016-04-20 |
东丽株式会社 |
生物降解性材料以及生物降解性材料的制造方法
|
JP6191455B2
(ja)
|
2012-03-28 |
2017-09-06 |
東レ株式会社 |
生分解性材料及び生分解性材料の製造方法
|
WO2013149219A2
(en)
|
2012-03-30 |
2013-10-03 |
Sorrento Therapeutics Inc. |
Fully human antibodies that bind to vegfr2
|
US8992595B2
(en)
|
2012-04-04 |
2015-03-31 |
Trivascular, Inc. |
Durable stent graft with tapered struts and stable delivery methods and devices
|
US9498363B2
(en)
|
2012-04-06 |
2016-11-22 |
Trivascular, Inc. |
Delivery catheter for endovascular device
|
EP2854869B1
(de)
|
2012-05-24 |
2017-11-01 |
Biosphere Medical Inc. |
Biomaterialien zur verwendung als wirkstofffreisetzende, mri-nachweisbare implantate für gefässverschluss
|
KR102323637B1
(ko)
*
|
2013-09-16 |
2021-11-08 |
바이오컴페터블즈 유케이 리미티드 |
유성 조성물
|
RU2613888C1
(ru)
*
|
2016-02-26 |
2017-03-21 |
государственное бюджетное учреждение здравоохранения "Санкт-Петербургский клинический научно-практический центр специализированных видов медицинской помощи (онкологический)" |
Способ предоперационного лечения больных с местно-распространенным раком шейки матки T1b2-T2b стадии
|
RU2619341C1
(ru)
*
|
2016-08-29 |
2017-05-15 |
Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации |
Способ коррекции гормонального статуса при посткастрационном синдроме у больных раком шейки матки репродуктивного возраста
|
WO2018058125A1
(en)
|
2016-09-26 |
2018-03-29 |
Ensemble Group Holdings |
Methods of assessing and treating cancer in subjects having dysregulated lymphatic systems
|
WO2019163012A1
(ja)
*
|
2018-02-21 |
2019-08-29 |
国立大学法人信州大学 |
液体塞栓剤組成物
|
ES2969226T3
(es)
*
|
2018-11-30 |
2024-05-17 |
Nextbiomedical Co Ltd |
Partículas de hidrogel para quimioembolización que comprenden un polímero biodegradable
|